Travere Therapeutics Inc.

Travere Therapeutics Inc.

World Rank (Jan-05-2024)
10,719
Market Cap (Jan-05-2024)
0.683 Billion USD
World Rank (Jul-30-2023)
7,507
Market Cap (Jul-30-2023)
1.287 Billion USD
World Rank (Jan-07-2022)
6,953
Market Cap (Jan-07-2022)
1.704 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TVTX
Market Cap (Mar-08-2026)
2.51
Employee Count
462
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
212 Million USD
Annual Operating Income in USD
-251 Million USD
Annual Net Income in USD
-278 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
672 Million USD
Total Liabilities in USD
629 Million USD
Total Equity in USD
43 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
TRAVERE THERAPEUTICS, INC.
Company Profile

Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.

Facts About Company

Travere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.

Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.

As on 2022, Travere Therapeutics has 462 employees.

Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share